Abstract
Quality control in the cytology laboratory comprises many aspects of laboratory practice that are common to all medical laboratories but some that are unique. In the application to cytology, there are further, special considerations. This chapter describes quality control and quality assurance activities specific to cytology which requires continuous monitoring and are mandatory by the Clinical Laboratory Improvement Amendments of 1988 (CLIA ‘88) regulations. This chapter also describes how to document review activities and monitor their effectiveness in improving performance in gynecological, non-gynecological, and fine needle aspiration cytology techniques.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Quality Improvement Manual in Anatomic Pathology. Chicago: College of American Pathologists; 1993.
Clinical Laboratory Improvement Amendments of 1988; Final Rule. Federal Register. 1992; 57: 493.1257.
Clinical Laboratory Improvement Amendments of 1988; Final Rule. Federal Register. 1992; 57: 493.1257(b).
Clinical Laboratory Improvement Amendments of 1988; Final Rule. Federal Register. 1992; 57: 493.1257(d)(3).
Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med. 2000;124:672–81.
Renshaw AA. Analysis of error in calculating the false-negative rate in the interpretation of cervicovaginal smears: the need to review abnormal cases. Cancer Cytopathol. 1997;81:264–71.
Clinical Laboratory Improvement Amendments of 1988; Final Rule. Federal Register. 2003; 68: 493.1255.
Zarbo RJ. Monitoring anatomic pathology practice through quality assurance measures. Clin Lab Med. 1999;19:713–42.
Clinical Laboratory Improvement Amendments of 1988; Final Rule. Federal Register.2003; 68: 493.1274(e)(3).
College of American Pathologists. Commission on Laboratory Accreditation Inspection Checklist 2002 edition, Northfield, Illinois.
Clinical Laboratory Improvement Amendments of 1988; Final Rule. Federal Register. 2003; 68: 493.1241(a).
Nagy GK. False negative rate – a misnomer, misunderstood and misused. Acta Cytol. 1997;41:778–80.
Krieger PA, Naryshkin S. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories. Acta Cytol. 1994;38:291–8.
Krieger PA, Cohen T, Naryshkin S. A practical guide to Papanicolaou smear rescreens. Cancer Cytopathol. 1998;84:130–7.
Jones BA, Novis DA. Nongynecologic cytology turnaround time: a College of American Pathologists Q-Probes study of 180 laboratories. Arch Pathol Lab Med. 2001;125(10):1279–84.
Rickert RR. Quality assurance in anatomic pathology. Clin Lab Med. 1986;6:697–706.
Acknowledgments
None
Conflicts of Interest and Disclaimer: None
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Harbhajanka, A., Michael, C.W. (2019). Quality Control for Cytology Laboratory in the USA. In: Kakudo, K. (eds) Thyroid FNA Cytology. Springer, Singapore. https://doi.org/10.1007/978-981-13-1897-9_67
Download citation
DOI: https://doi.org/10.1007/978-981-13-1897-9_67
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1896-2
Online ISBN: 978-981-13-1897-9
eBook Packages: MedicineMedicine (R0)